TRCT
GPAT

Tower Research Capital (TRC)’s GP-Act III Acquisition Corp GPAT Stock Holding History

Tower Research Capital (TRC)’s Portfolio GPAT Stock Details GPAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-120
Closed -$1.22K – 5922
2024
Q4 		$1.22K Sell
120
-103
-46% -$1.04K ﹤0.01% 5064
2024
Q3 		$2.25K Buy
+223
New +$2.23K ﹤0.01% 5024

Other funds holding GPAT

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Tower Research Capital (TRC)'s GPAT Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of GP-Act III Acquisition Corp (GPAT) in Q1 2025, closing a stake of 120 shares — an estimated $1.22K sold.

Tower Research Capital (TRC) first reported a position in GPAT in Q3 2024 and held it in 2 quarters. The position peaked at $2.25K in Q3 2024. 40 funds tracked by Wall St. Rank hold GPAT as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining GP-Act III Acquisition Corp position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 120 GP-Act III Acquisition Corp shares in Q1 2025, an estimated $1.22K.
  • Tower Research Capital (TRC) first reported a position in GP-Act III Acquisition Corp in Q3 2024 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s GP-Act III Acquisition Corp position peaked at $2.25K in Q3 2024.
  • 40 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.